Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00641_DB01319_nanopub.RAo-D_yqw3rWr1aMB7TMK_zPHQ_Z1oNQNY-_BMBl0pRfs#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00641_DB01319 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00641_DB01319 label "DDI between Simvastatin and Fosamprenavir - Fosamprenavir, a strong CYP3A4 inhibitor, may increase the serum concentration of simvastatin by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of simvastatin if fosamprenavir is initiated, discontinued or dose changed. [drugbank_resource:DB00641_DB01319]" assertion.
- drugbank_resource:DB00641_DB01319 identifier "drugbank_resource:DB00641_DB01319" assertion.
- drugbank_resource:DB00641_DB01319 title "DDI between Simvastatin and Fosamprenavir - Fosamprenavir, a strong CYP3A4 inhibitor, may increase the serum concentration of simvastatin by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of simvastatin if fosamprenavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB00641 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00641_DB01319 assertion.
- drugbank:DB01319 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00641_DB01319 assertion.